FindTrial
Sign In

Omnipaque 350 mg I/ml Injektionslösung

DRUG2 trials

Sponsors

University Of Helsinki, Centre Hospitalier Universitaire De La Reunion

Conditions

EndometriosisPatients requiring emergency abdominal or body CT with eGFR 15-45 ml/min/1.73 m2. The eGFR is calculated from the last available plasma creatinine value taken maximum 24 hours before randomisation.

Phase 3

Contribution of PET (positron emission tomography) scans for the preoperative assessment of symptomatic endometriosis lesions: TEP-ENDORUN
CompletedCTIS2024-520423-88-00
Centre Hospitalier Universitaire De La ReunionEndometriosis
Start: 2025-02-01End: 2025-04-24Target: 15Updated: 2025-01-29

Phase 4

INtravenous Contrast computed tomography versus native computed tomography in patients with acute Abdomen and impaired Renal functiOn (INCARO) – a multicentre, open-label, randomised controlled trial
Not yet recruitingCTIS2024-512084-31-00
University Of HelsinkiPatients requiring emergency abdominal or body CT with eGFR 15-45 ml/min/1.73 m2. The eGFR is calculated from the last available plasma creatinine value taken maximum 24 hours before randomisation.
Target: 994Updated: 2025-08-15